Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Live Updating

dirtydozen911

10/01/24 3:54 PM

Post #6

dont know why , but this P O S is up 125% at 30 mins ago scanner picked up low vol spike.

TooFrank

11/15/22 8:07 PM

Post #4

Colorado just legalized ‘magic mushrooms,’ an idea that’s growing nationwide

The initiative allows for the use of psilocybin at state-regulated centers under the supervision of licensed facilitators.
It also legalizes personal private use, growing and sharing of psilocybin and psilocin, as well as three additional psychedelic compounds — DMT, ibogaine and mescaline — by adults over the age of 21. Retail sales are not permitted,…

https://www.cnbc.com/amp/2022/11/12/colorado-just-legalized-magic-mushrooms-an-idea-thats-growing-nationwide.html

TooFrank

09/13/22 9:55 PM

Post #3

Hannam & Partners Financial Promotion of PSYGF

Psyence Group (PSYGF)
First mover into palliative care market supported
by natural psilocybin production
https://psyence.com/wp-content/uploads/2022/09/Psyence_Initiation_FINAL.02.pdf

Hannam & Partners Disclamer
https://www.hannam.partners/disclaimer/
Any Research Product is likely to be considered a financial promotion for the purposes of the FCA Rules.

Any Research Product provided by Hannam & Partners (“H&P”) will constitute “non-independent research” for the purposes of the rules from time to time of the Financial Conduct Authority (“FCA Rules”). As such it will constitute a marketing communication, has not been prepared in accordance with legal requirements designed to promote the independence of investment research and is not subject to any prohibition on dealing ahead of the dissemination of investment research.

TooFrank

09/06/22 5:43 PM

Post #2

Psyence operates one of the first and only federally licensed commercial psilocybin production facilities in the world. Is licensed to cultivate and export psilocybin mushrooms for the legal, global medical market and commercial medical research market.

Preparing to send mushrooms to Canada and Spain for analysis and extraction.

The laboratory has also been expanded to having the capability and equipment to undertake in-process testing on site, crude extraction, as well as to generate Certificates of Analysis (COAs) and undertake testing of the end product.